
Sara Elizabeth Townsley
Examiner (ID: 5080, Phone: (571)270-7672 , Office: P/1629 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1612, 1613 |
| Total Applications | 512 |
| Issued Applications | 97 |
| Pending Applications | 84 |
| Abandoned Applications | 350 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5429157
[patent_doc_number] => 20090088467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'VITAMIN E SUPPLEMENTATION TO TETANUS TOXOID'
[patent_app_type] => utility
[patent_app_number] => 12/243839
[patent_app_country] => US
[patent_app_date] => 2008-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12446
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20090088467.pdf
[firstpage_image] =>[orig_patent_app_number] => 12243839
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/243839 | Vitamin E supplementation to tetanus toxoid | Sep 30, 2008 | Issued |
Array
(
[id] => 6403072
[patent_doc_number] => 20100305214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'Use of a Monoterpene to Increase Tissue Repair'
[patent_app_type] => utility
[patent_app_number] => 12/679995
[patent_app_country] => US
[patent_app_date] => 2008-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7040
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20100305214.pdf
[firstpage_image] =>[orig_patent_app_number] => 12679995
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/679995 | Use of a Monoterpene to Increase Tissue Repair | Sep 26, 2008 | Abandoned |
Array
(
[id] => 6453751
[patent_doc_number] => 20100189672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'DECALINE DERIVATIVES AS PERFUMING INGREDIENTS'
[patent_app_type] => utility
[patent_app_number] => 12/677723
[patent_app_country] => US
[patent_app_date] => 2008-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4456
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20100189672.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677723
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677723 | DECALINE DERIVATIVES AS PERFUMING INGREDIENTS | Sep 22, 2008 | Abandoned |
Array
(
[id] => 6388603
[patent_doc_number] => 20100317679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'SUBSTITUTED ARYL-FUSED SPIROCYCLIC AMINES'
[patent_app_type] => utility
[patent_app_number] => 12/678782
[patent_app_country] => US
[patent_app_date] => 2008-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18870
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317679.pdf
[firstpage_image] =>[orig_patent_app_number] => 12678782
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/678782 | SUBSTITUTED ARYL-FUSED SPIROCYCLIC AMINES | Sep 18, 2008 | Abandoned |
Array
(
[id] => 5272187
[patent_doc_number] => 20090075963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'TRANSDERMAL HORMONE SPRAY'
[patent_app_type] => utility
[patent_app_number] => 12/209961
[patent_app_country] => US
[patent_app_date] => 2008-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9241
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20090075963.pdf
[firstpage_image] =>[orig_patent_app_number] => 12209961
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/209961 | TRANSDERMAL HORMONE SPRAY | Sep 11, 2008 | Abandoned |
Array
(
[id] => 5350081
[patent_doc_number] => 20090005442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING NEURODEGENERATIVE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/207816
[patent_app_country] => US
[patent_app_date] => 2008-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6048
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20090005442.pdf
[firstpage_image] =>[orig_patent_app_number] => 12207816
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/207816 | CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING NEURODEGENERATIVE DISORDERS | Sep 9, 2008 | Abandoned |
Array
(
[id] => 5324416
[patent_doc_number] => 20090062406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'Aqueous concentrates of isethionate, taurate and betaine'
[patent_app_type] => utility
[patent_app_number] => 12/231209
[patent_app_country] => US
[patent_app_date] => 2008-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4782
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062406.pdf
[firstpage_image] =>[orig_patent_app_number] => 12231209
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/231209 | Aqueous concentrates of isethionate, taurate and betaine | Aug 28, 2008 | Abandoned |
Array
(
[id] => 5958434
[patent_doc_number] => 20110182821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'CLUSTERED MAGNETIC PARTICLES AS TRACERS FOR MAGNETIC PARTICLE IMAGING'
[patent_app_type] => utility
[patent_app_number] => 12/674444
[patent_app_country] => US
[patent_app_date] => 2008-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2737
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20110182821.pdf
[firstpage_image] =>[orig_patent_app_number] => 12674444
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/674444 | CLUSTERED MAGNETIC PARTICLES AS TRACERS FOR MAGNETIC PARTICLE IMAGING | Aug 27, 2008 | Abandoned |
Array
(
[id] => 5336712
[patent_doc_number] => 20090053176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'New Combination 937'
[patent_app_type] => utility
[patent_app_number] => 12/195505
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10121
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053176.pdf
[firstpage_image] =>[orig_patent_app_number] => 12195505
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/195505 | New Combination 937 | Aug 20, 2008 | Abandoned |
Array
(
[id] => 5984819
[patent_doc_number] => 20110097410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'FORMULATIONS OF PX COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/674743
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7023
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20110097410.pdf
[firstpage_image] =>[orig_patent_app_number] => 12674743
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/674743 | FORMULATIONS OF PX COMPOUNDS | Aug 20, 2008 | Abandoned |
Array
(
[id] => 8577815
[patent_doc_number] => 08344025
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-01
[patent_title] => 'Oxalic acid derivatives and use thereof as physiological cooling active ingredients'
[patent_app_type] => utility
[patent_app_number] => 12/193375
[patent_app_country] => US
[patent_app_date] => 2008-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18085
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12193375
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/193375 | Oxalic acid derivatives and use thereof as physiological cooling active ingredients | Aug 17, 2008 | Issued |
Array
(
[id] => 5447007
[patent_doc_number] => 20090048233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination'
[patent_app_type] => utility
[patent_app_number] => 12/192591
[patent_app_country] => US
[patent_app_date] => 2008-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28965
[patent_no_of_claims] => 143
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20090048233.pdf
[firstpage_image] =>[orig_patent_app_number] => 12192591
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/192591 | Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination | Aug 14, 2008 | Abandoned |
Array
(
[id] => 7731725
[patent_doc_number] => 20120015032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/672630
[patent_app_country] => US
[patent_app_date] => 2008-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17542
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015032.pdf
[firstpage_image] =>[orig_patent_app_number] => 12672630
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/672630 | COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME | Aug 7, 2008 | Abandoned |
Array
(
[id] => 5297248
[patent_doc_number] => 20090012174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Compositions Having a High Antiviral and Antibacterial Efficacy'
[patent_app_type] => utility
[patent_app_number] => 12/188714
[patent_app_country] => US
[patent_app_date] => 2008-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15872
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012174.pdf
[firstpage_image] =>[orig_patent_app_number] => 12188714
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/188714 | Compositions Having a High Antiviral and Antibacterial Efficacy | Aug 7, 2008 | Abandoned |
Array
(
[id] => 7817501
[patent_doc_number] => 20120064121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'PYRIDINE COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES'
[patent_app_type] => utility
[patent_app_number] => 12/452983
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18333
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20120064121.pdf
[firstpage_image] =>[orig_patent_app_number] => 12452983
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452983 | PYRIDINE COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES | Jul 30, 2008 | Abandoned |
Array
(
[id] => 5361664
[patent_doc_number] => 20090036458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'ENDOPARASITICIDAL TOPICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/182253
[patent_app_country] => US
[patent_app_date] => 2008-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2497
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20090036458.pdf
[firstpage_image] =>[orig_patent_app_number] => 12182253
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/182253 | ENDOPARASITICIDAL TOPICAL COMPOSITIONS | Jul 29, 2008 | Abandoned |
Array
(
[id] => 5447114
[patent_doc_number] => 20090048340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'GROWTH HORMONE SECRETION REGULATOR'
[patent_app_type] => utility
[patent_app_number] => 12/182544
[patent_app_country] => US
[patent_app_date] => 2008-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6029
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20090048340.pdf
[firstpage_image] =>[orig_patent_app_number] => 12182544
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/182544 | GROWTH HORMONE SECRETION REGULATOR | Jul 29, 2008 | Abandoned |
Array
(
[id] => 5338012
[patent_doc_number] => 20090054476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'A3 Adenosine receptor allosteric modulators'
[patent_app_type] => utility
[patent_app_number] => 12/219772
[patent_app_country] => US
[patent_app_date] => 2008-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16166
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054476.pdf
[firstpage_image] =>[orig_patent_app_number] => 12219772
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/219772 | A3 adenosine receptor allosteric modulators | Jul 27, 2008 | Issued |
Array
(
[id] => 5453230
[patent_doc_number] => 20090069267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'CENTRAL ADMINISTRATION OF STABLE FORMULATIONS OF THERAPEUTIC AGENTS FOR CNS CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/180373
[patent_app_country] => US
[patent_app_date] => 2008-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 22104
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20090069267.pdf
[firstpage_image] =>[orig_patent_app_number] => 12180373
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/180373 | CENTRAL ADMINISTRATION OF STABLE FORMULATIONS OF THERAPEUTIC AGENTS FOR CNS CONDITIONS | Jul 24, 2008 | Abandoned |
Array
(
[id] => 6455367
[patent_doc_number] => 20100189783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'RELATING TO ANTI-HIV TABLET FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/670030
[patent_app_country] => US
[patent_app_date] => 2008-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3470
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20100189783.pdf
[firstpage_image] =>[orig_patent_app_number] => 12670030
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/670030 | RELATING TO ANTI-HIV TABLET FORMULATIONS | Jul 24, 2008 | Abandoned |